Dupixent also significantly reduced oral corticosteroid and rescue medicine use compared to placebo Data support the potential of Dupixent to be the first and only targeted medicine to treat bullous ...

DUPIXENT is not used to relieve sudden breathing problems and will not replace an inhaled rescue medicine. have eye problems. have a parasitic (helminth) infection. are scheduled to receive any ...

DUPIXENT is not used to relieve sudden breathing problems and will not replace an inhaled rescue medicine. have eye problems. have a parasitic (helminth) infection. are scheduled to receive any ...

Dupixent was previously granted Orphan Drug Designation by the FDA for BP, which applies to investigational medicines intended for the treatment of rare diseases that affect fewer than 200,000 ...

In CUPID STUDY B, IL-4 and IL-13 inhibitor Dupixent (dupilumab) wasn't able to achieve a significant improvement in symptoms in Xolair-refractory CSU patients, and will be stopped for futility ...

Sanofi and Regeneron’s immunology juggernaut Dupixent is on the brink of another big new indication after it was recommended by the EMA’s human medicines committee for chronic obstructive ...

If approved, Dupixent would be the first and only targeted medicine to treat bullous pemphigoid in the U.S. The submission was supported by a pivotal study which met its primary endpoint.